Detalhe da pesquisa
1.
Cortical Microhemorrhage Presentation of Small Vessel Primary Angiitis of the Central Nervous System.
Ann Neurol
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38661030
2.
Central vein sign and trigeminal lesions of multiple sclerosis visualised by 7T MRI.
J Neurol Neurosurg Psychiatry
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38453475
3.
The difference of the retinal structural and microvascular characteristics in patients with MOGAD-ON and AQP4-ON.
BMC Neurol
; 22(1): 323, 2022 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36030231
4.
Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS.
J Neurol Neurosurg Psychiatry
; 92(7): 709-716, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33687975
5.
Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow.
Ann Neurol
; 84(5): 717-728, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30295338
6.
Bidirectional degeneration in the visual pathway in neuromyelitis optica spectrum disorder (NMOSD).
Mult Scler
; 24(12): 1585-1593, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28823217
7.
Efficacy and safety of apheresis therapy in AQP4 antibody-positive NMOSD attack: A propensity score-matched cohort study.
CNS Neurosci Ther
; 30(5): e14780, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38790106
8.
Independent and reproducible hippocampal radiomics biomarkers for multisite multiple sclerosis and neuromyelitis optica spectrum disorders.
Mult Scler Relat Disord
; 81: 105146, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38007962
9.
Efficacy and safety of low- and ultralow-dose rituximab in neuromyelitis optica spectrum disorder.
J Neuroimmunol
; 387: 578285, 2024 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38219400
10.
APOE from patient-derived astrocytic extracellular vesicles alleviates neuromyelitis optica spectrum disorder in a mouse model.
Sci Transl Med
; 16(736): eadg5116, 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38416841
11.
Treatment algorithms of relapsing multiple sclerosis: an exploration based on the available disease-modifying therapies in China.
Ther Adv Neurol Disord
; 17: 17562864241239117, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38616782
12.
White matter disease derived from vascular and demyelinating origins.
Stroke Vasc Neurol
; 2023 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37699727
13.
Incidence of Guillain-Barré syndrome (GBS) in China: A national population-based study.
Lancet Reg Health West Pac
; 18: 100302, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35024648
14.
Clinical, imaging features and treatment response of idiopathic hypertrophic pachymeningitis.
Mult Scler Relat Disord
; 66: 104026, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35868153
15.
Persistently Gadolinium-Enhancing Lesion Is a Predictor of Poor Prognosis in NMOSD Attack: a Clinical Trial.
Neurotherapeutics
; 18(2): 868-877, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33469828
16.
Thymic Involution and Altered Naive CD4 T Cell Homeostasis in Neuromyelitis Optica Spectrum Disorder.
Front Immunol
; 12: 645277, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34335563
17.
Corrigendum to 'Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: A national population-based study'.
Lancet Reg Health West Pac
; 8: 100118, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34374699
18.
The occurrence of myelin oligodendrocyte glycoprotein antibodies in aquaporin-4-antibody seronegative Neuromyelitis Optica Spectrum Disorder: A systematic review and meta-analysis.
Mult Scler Relat Disord
; 53: 103030, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34118585
19.
Cellular and molecular imaging for stem cell tracking in neurological diseases.
Stroke Vasc Neurol
; 6(1): 121-127, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33122254
20.
Incidence of multiple sclerosis in China: A nationwide hospital-based study.
Lancet Reg Health West Pac
; 1: 100010, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34327341